Abstract:
Liver cirrhosis is a chronic condition imposing a considerable burden on patients, families, health care, and society. Assessment of health-related quality of life (QOL) is particularly important for these patients in view of the paucity of therapies substantially improving their survival except for liver transplantation. To date several investigators employing numerous generic and disease-specific QOL measurement instruments have reported poor QOL in these patients irrespective of the etiology of liver disease. Apart from the severity and complications of liver cirrhosis several disease-specific symptoms (such as pruritus, muscle cramps, sleep disturbance, sexual dysfunction, fatigue, and gastrointestinal symptoms) have been shown to be of importance in determining QOL in this patient group. Liver transplantation has been repeatedly shown to improve QOL. However, some of the few studies evaluating the impact of other medical interventions on QOL in cirrhotics have demonstrated that various treatment modalities may improve survival or decrease complication risk but they do not invariably improve patients’ QOL which stresses the need for rigorous selection of patients suitable for a specific type of treatment. Last, the value cirrhotic patients place on the state of their health differs from that assigned by physicians. Thus, in cost-utility analysis, which is based on quality-adjusted life years, utilities should be based on patient reports.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- AUSQUAL:
-
Austin quality of life scale
- BDI:
-
Beck depression inventory
- BSI:
-
brief symptom inventory
- CC:
-
compensated cirrhosis
- CLDQ:
-
chronic liver disease questionnaire
- CLD-QOL:
-
chronic liver disease quality of life questionnaire
- DC:
-
decompensated cirrhosis
- GSRS:
-
gastrointestinal symptom rating scale
- HAD:
-
hospital anxiety and depression index
- LDQOL:
-
liver disease quality of life instrument
- LDSI:
-
liver disease symptom index
- LTX:
-
liver transplantation
- MELD:
-
model for end-stage liver disease
- MFI-20:
-
multidimensional fatigue index – 20
- NC:
-
non-cirrhotic control patients
- NHP:
-
Nottingham health profile
- PGWBI:
-
psychological general well-being index
- QOL:
-
quality of life
- SF-36:
-
36-item short form health survey
- SIP:
-
sickness impact profile
- TIPS:
References
Arguedas MR, DeLawrence TG, McGuire BM. (2003). Dig Dis Sci. 48: 1622–1626.
Bajaj JS, Hafeezullah M, Hoffmann RG, Saeian K. (2007). Am J Gastroenterol. 102: 1903–1909.
Bajaj JS, Hafeezullah M, Hoffmann RG, Varma RR, Franco J, Binion DG, Hammeke TA, Saeian K. (2008). Hepatology. 47: 596–604.
Belle SH, Porayko MK, Hoofnagle JH, Lake JR, Zetterman RK. (1997). Liver Transpl Surg. 3: 93–104.
Bianchi G, Loguercio C, Sgarbi D, Abbiati R, Brunetti N, De Simone T, Zoli M, Marchesini G. (2003). Dig Liver Dis. 35: 46–54.
Bianchi G, Marchesini G, Nicolino F, Graziani R, Sgarbi D, Loguercio C, Abbiati R, Zoli M. (2005). Dig Liver Dis. 37: 593–600.
Björnsson E, Simren M, Olsson R, Chapman RW. (2005). Eur J Gastroenterol Hepatol. 17: 351–357.
Bonkovsky HL, Snow KK, Malet PF, Back-Madruga C, Fontana RJ, Sterling RK, Kulig CC, Di Bisceglie AM, Morgan TR, Dienstag JL, Ghany MG, Gretch DR. (2007). J Hepatol. 46: 420–431.
Borgaonkar MR, Irvine EJ. (2000). Gut. 47: 444–454.
Campbell MS, Brensinger CM, Sanyal AJ, Gennings C, Wong F, Kowdley KV, McCashland T, Reddy KR. (2005). Hepatology. 42: 635–640.
Casanovas Taltavull T, Vallejo Blanxart G, Herdman M, Verge Monedero JM, Tremosa Llurba G, Rodriguez Farina E, Ramos Rubio E, Baliellas Comellas C, Figueras Felip J, Menchon Magrina JM, Casais Alvarez LA. (2003). Gastroenterol Hepatol. 26: 234–244.
Cordoba J, Cabrera J, Lataif L, Penev P, Zee P, Blei AT. (1998). Hepatology. 27: 339–345.
Cordoba J, Flavia M, Jacas C, Sauleda S, Esteban JI, Vargas V, Esteban R, Guardia J. (2003). J Hepatol. 39: 231–238.
Cornely CM, Schade RR, Van Thiel DH, Gavaler JS. (1984). Hepatology. 4: 1227–1230.
De Bona M, Ponton P, Ermani M, Iemmolo RM, Feltrin A, Boccagni P, Gerunda G, Naccarato R, Rupolo G, Burra P. (2000). J Hepatol. 33: 609–615.
Ferrer M, Cordoba J, Garin O, Olive G, Flavia M, Vargas V, Esteban R, Alonso J. (2006). Liver Transpl. 12: 95–104.
Goldblatt J, Taylor PJ, Lipman T, Prince MI, Baragiotta A, Bassendine MF, James OF, Jones DE. (2002). Gastroenterology. 122: 1235–1241.
Gralnek IM, Hays RD, Kilbourne A, Rosen HR, Keeffe EB, Artinian L, Kim S, Lazarovici D, Jensen DM, Busuttil RW, Martin P. (2000). Am J Gastroenterol. 95: 3552–3565.
Groeneweg M, Quero JC, De Bruijn I, Hartmann IJ, Essink-bot ML, Hop WC, Schalm SW. (1998). Hepatology. 28: 45–49.
Gross CR, Malinchoc M, Kim WR, Evans RW, Wiesner RH, Petz JL, Crippin JS, Klintmalm GB, Levy MF, Ricci P, Therneau TM, Dickson ER. (1999). Hepatology. 29: 356–364.
Gulberg V, Liss I, Bilzer M, Waggershauser T, Reiser M, Gerbes AL. (2002). Digestion. 66: 127–130.
Hauser W, Holtmann G, Grandt D. (2004a). Clin Gastroenterol Hepatol. 2: 157–163.
Hauser W, Schnur M, Steder-Neukamm U, Muthny FA, Grandt D. (2004b). Eur J Gastroenterol Hepatol. 16: 599–606.
Huet PM, Deslauriers J, Tran A, Faucher C, Charbonneau J. (2000). Am J Gastroenterol. 95: 760–767.
Kalaitzakis E, Björnsson E. (2007). Gastroenterology. 132: A475.
Kalaitzakis E, Simren M, Olsson R, Henfridsson P, Hugosson I, Bengtsson M, Bjornsson E. (2006). Scand J Gastroenterol. 41: 1464–1472.
Kanwal F, Hays RD, Kilbourne AM, Dulai GS, Gralnek IM. (2004). Am J Gastroenterol. 99: 1726–1732.
Karam V, Castaing D, Danet C, Delvart V, Gasquet I, Adam R, Azoulay D, Samuel D, Bismuth H. (2003). Liver Transpl. 9: 703–711.
Lee EH, Cheong JY, Cho SW, Hahm KB, Kim HY, Park JJ, Lee DH, Kim SK, Choi SR, Lee ST, Moon SM. (2008). J Gastroenterol Hepatol. 23: 231–238.
Marchesini G, Bianchi G, Amodio P, Salerno F, Merli M, Panella C, Loguercio C, Apolone G, Niero M, Abbiati R. (2001). Gastroenterology. 120: 170–178.
Moore KA, Mc LJR, Burrows GD. (2000). Liver Transpl. 6: 633–642.
Norman K, Kirchner H, Lochs H, Pirlich M. (2006). World J Gastroenterol. 12: 3380–3385.
Prasad S, Dhiman RK, Duseja A, Chawla YK, Sharma A, Agarwal R. (2007). Hepatology. 45: 549–559.
Rucci P, Taliani G, Cirrincione L, Alberti A, Bartolozzi D, Caporaso N, Colombo M, Coppola R, Chiaramonte M, Craxi A, De Sio I, Floreani AR, Gaeta GB, Persico M, Secchi G, Versace I, Mele A. (2005). Dig Liver Dis. 37: 850–860.
Saab S, Ibrahim AB, Shpaner A, Younossi ZM, Lee C, Durazo F, Han S, Esrason K, Wu V, Hiatt J, Farmer DG, Ghobrial RM, Holt C, Yersiz H, Goldstein LI, Tong MJ, Busuttil RW. (2005). Liver Transpl. 11: 218–223.
Schomerus H, Hamster W. (2001). Metab Brain Dis. 16: 37–41.
Sherlock S, Dooley J. (2002). Sherlock S, Dooley J (ed.) “Diseases of the liver and biliary system”. Blackwell Publishing, Milan, pp. 365–380.
Singh N, Gayowski T, Wagener MM, Marino IR. (1997). Dig Dis Sci. 42: 1421–1427.
Sullivan M, Karlsson J, Taft C, Ware JE. (2002). “SF-36 Health Survey: Swedish Manual and Interpretation Guide, 2nd ed.” Sahlgrenska University Hospital, Gothenburg.
Tarter RE, Switala J, Arria A, Plail J, Van Thiel D. (1991). Arch Intern Med. 151: 1521–1526.
Tarter RE, Switala J, Plail J, Havrilla J, Van Thiel DH. (1992). Arch Intern Med. 152: 2097–2101.
Toda K, Miwa Y, Kuriyama S, Fukushima H, Shiraki M, Murakami N, Shimazaki M, Ito Y, Nakamura T, Sugihara J, Tomita E, Nagata C, Suzuki K, Moriwaki H. (2005). J Gastroenterol. 40: 894–900.
Plas SM, van der Hansen BE, de Boer JB, Stijnen T, Passchier J, de Man RA, Schalm SW. (2003). BMC Gastroenterol. 3: 33. http://www.biomedcentral.com/1471–1230X/1473/1433.
Plas SM, van der Hansen BE, de Boer JB, Stijnen T, Passchier J, de Man RA, Schalm SW. (2004). Qual Life Res. 13: 1469–1481.
Wein C, Koch H, Popp B, Oehler G, Schauder P. (2004). Hepatology. 39: 739–745.
Wells CD, Murrill WB, Arguedas MR. (2004). Dig Dis Sci. 49: 453–458.
Younossi ZM, Boparai N, McCormick M, Price LL, Guyatt G. (2001a). Am J Gastroenterol. 96: 579–583.
Younossi ZM, Boparai N, Price LL, Kiwi ML, McCormick M, Guyatt G. (2001b). Am J Gastroenterol. 96: 2199–2205.
Younossi ZM, Guyatt G, Kiwi M, Boparai N, King D. (1999). Gut. 45: 295–300.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media LLC
About this entry
Cite this entry
Kalaitzakis, E. (2010). Quality of Life in Liver Cirrhosis. In: Preedy, V.R., Watson, R.R. (eds) Handbook of Disease Burdens and Quality of Life Measures. Springer, New York, NY. https://doi.org/10.1007/978-0-387-78665-0_131
Download citation
DOI: https://doi.org/10.1007/978-0-387-78665-0_131
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-78664-3
Online ISBN: 978-0-387-78665-0
eBook Packages: MedicineReference Module Medicine